ReviewTherapeutic advances in cardiovascular disease

Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use.

Davide Capodanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.